The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Hyperhomocysteinemia and Low Pyridoxal Phosphate: Common and Independent Reversible Risk Factors for Coronary Artery Disease
Abstract
Background High plasma homocysteine is associated with premature coronary artery disease in men, but the threshold concentration defining this risk and its importance in women and the elderly are unknown. Furthermore, although low B vitamin status increases homocysteine, the link between these vitamins and coronary disease is unclear. Methods and Results We compared 304 patients with coronary disease with 231 control subjects. Risk factors and concentrations of plasma homocysteine, folate, vitamin B12, and pyridoxal 5′-phosphate were documented. A homocysteine concentration of 14 μmol/L conferred an odds ratio of coronary disease of 4.8 ( P <.001), and 5-μmol/L increments across the range of homocysteine conferred an odds ratio of 2.4 ( P <.001). Odds ratios of 3.5 in women and of 2.9 in those 65 years or older were seen ( P <.05). Homocysteine correlated negatively with all vitamins. Low pyridoxal 5′-phosphate (<20 nmol/L) was seen in 10% of patients but in only 2% of control subjects ( P <.01), yielding an odds ratio of coronary disease adjusted for all risk factors, including high homocysteine, of 4.3 ( P <.05). Conclusions Within the range currently considered to be normal, the risk for coronary disease rises with increasing plasma homocysteine regardless of age and sex, with no threshold effect. In addition to a link with homocysteine, low pyridoxal-5′-phosphate confers an independent risk for coronary artery disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Frosst, P., Blom, H. J., Milos, R., Goyette, P., Sheppard, C. A., Matthews, R. G., Boers, G. J. H., den Heijer, M., Kluijtmans, L. A. J., van den Heuve, L. P., et al. (1995) · Nature Genetics · doi:10.1038/ng0595-111 · Cited by 5,653
Hyperhomocysteinemia: An Independent Risk Factor for Vascular Disease
Clarke, R., Daly, L., Robinson, K., Naughten, E., Cahalane, S., Fowler, B., & Graham, I. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104253241701 · Cited by 2,161
Self-citationVitamin Status and Intake as Primary Determinants of Homocysteinemia in an Elderly Population
Selhub, J. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510220049033 · Cited by 1,972
Self-citationA Prospective Study of Plasma Homocyst(e)ine and Risk of Myocardial Infarction in US Physicians
Stampfer, M. J. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03490070059042 · Cited by 1,709
Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery Stenosis
Selhub, J., Jacques, P. F., Bostom, A. G., D'Agostino, R. B., Wilson, P. W. F., Belanger, A. J., O'Leary, D. H., Wolf, P. A., Schaefer, E. J., & Rosenberg, I. H. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502023320502 · Cited by 1,216
Self-citationMudd, S. H. (1989) · Medical Entomology and Zoology · Cited by 1,019
Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification
Goyette, P., Sumner, J. S., Milos, R., Duncan, A. M. V., Rosenblatt, D. S., Matthews, R. G., & Rozen, R. (1994) · Nature Genetics · doi:10.1038/ng0694-195 · Cited by 892
Heterozygosity for Homocystinuria in Premature Peripheral and Cerebral Occlusive Arterial Disease
Boers, G. H. J., Smals, A. G. H., Trijbels, F. J. M., Fowler, B., Bakkeren, J. A. J. M., Schoonderwaldt, H. C., Kleijer, W. J., & Kloppenborg, P. W. C. (1985) · New England Journal of Medicine · doi:10.1056/nejm198509193131201 · Cited by 732
Kang, S. S., WONG, P. W. K., Susmano, A., Sora, J., Norušis, M. J., & Ruggie, N. (1991) · PubMed · Cited by 600
The pathogenesis of coronary artery disease. A possible role for methionine metabolism.
Wilcken, D. E., & Wilcken, B. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108350 · Cited by 529
Cited by
Homocysteine and Cardiovascular Disease
Refsum, H., Ueland, P. M., Nygård, O., & Vollset, S. E. (1998) · Annual Review of Medicine · doi:10.1146/annurev.med.49.1.31 · Cited by 2,180
Homocysteine and Risk of Ischemic Heart Disease and Stroke: A Meta-analysis
Homocysteine Studies Collaboration (2002) · JAMA · doi:10.1001/jama.288.16.2015 · Cited by 2,059
Plasma Homocysteine Levels and Mortality in Patients with Coronary Artery Disease
Nygård, O., Nordrehaug, J. E., Refsum, H., Ueland, P. M., Farstad, M., & Vollset, S. E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707243370403 · Cited by 1,756
Homocysteine and vascular disease
Hankey, G. J., & Eikelboom, J. W. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11058-9 · Cited by 1,052
Homocyst(e)ine and Cardiovascular Disease: A Critical Review of the Epidemiologic Evidence
Eikelboom, J. W., Lonn, E., Genest, J., Hankey, G., & Yusuf, S. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-5-199909070-00008 · Cited by 908
The oxidant stress of hyperhomocyst(e)inemia.
Loscalzo, J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118776 · Cited by 717
Werstuck, G. H., Lentz, S. R., Dayal, S., Hossain, G. S., Sood, S. K., Shi, Y. Y., Zhou, J., Maeda, N., Krisans, S. K., Malinow, M. R., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11596 · Cited by 702
Folsom, A. R., Nieto, F. J., McGovern, P. G., Tsai, M. Y., Malinow, M. R., Eckfeldt, J. H., Hess, D. L., & Davis, C. E. (1998) · Circulation · doi:10.1161/01.cir.98.3.204 · Cited by 603
Malinow, M. R., Bostom, A. G., & Krauss, R. M. (1999) · Circulation · doi:10.1161/01.cir.99.1.178 · Cited by 586
Robinson, K., Arheart, K., Refsum, H., Brattström, L., Boers, G., Ueland, P., Rubba, P., Palma-Reis, R., Meleady, R., Daly, L., et al. (1998) · Circulation · doi:10.1161/01.cir.97.5.437 · Cited by 550
Self-citationHomocysteine and coronary atherosclerosis
Mayer, E. L., Jacobsen, D. W., & Robinson, K. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00508-0 · Cited by 519
Self-citationThe controversy over homocysteine and cardiovascular risk
Ueland, P. M., Refsum, H., Beresford, S. A., & Vollset, S. E. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.2.324 · Cited by 517
Homocysteine and cardiovascular disease: cause or effect?
Brattström, L., & Wilcken, D. E. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.2.315 · Cited by 439
Homocysteine and vitamins in cardiovascular disease
Jacobsen, D. W. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.8.1833 · Cited by 418
Self-citationMoustapha, A., Naso, A., Nahlawi, M., Gupta, A., Arheart, K. L., Jacobsen, D. W., Robinson, K., & Dennis, V. W. (1998) · Circulation · doi:10.1161/01.cir.97.2.138 · Cited by 405
Self-citationUpdate on Cobalamin, Folate, and Homocysteine
Carmel, R., Green, R., Rosenblatt, D. S., & Watkins, D. (2003) · Hematology · doi:10.1182/asheducation-2003.1.62 · Cited by 391
Self-citationHyperhomocysteinemia, Atherosclerosis and Thrombosis
Cattaneo, M. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614438 · Cited by 362
Homocyst(e)ine and Risk of Cardiovascular Disease in the Multiple Risk Factor Intervention Trial
Evans, R. W., Shaten, B. J., Hempel, J. D., Cutler, J. A., & Kuller, L. H. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.10.1947 · Cited by 342
Robinson, K., Gupta, A., Dennis, V., Arheart, K., Chaudhary, D., Green, R., Vigo, P., Mayer, E. L., Selhub, J., Kutner, M., et al. (1996) · Circulation · doi:10.1161/01.cir.94.11.2743 · Cited by 334
Self-citationMeta-analysis of Hyperhomocysteinemia as a Risk Factor for Venous Thromboembolic Disease
Ray, J. G. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.19.2101 · Cited by 321
Tonstad, S., Joakimsen, O., Stensland-Bugge, E., Leren, T. P., Ose, L., Russell, D., & Bønaa, K. H. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.8.984 · Cited by 314
Blood Levels of Homocysteine and Increased Risks of Cardiovascular Disease: Causal or Casual?
Christen, W. G., Ajani, U. A., Glynn, R. J., & Hennekens, C. H. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.4.422 · Cited by 304
Risk factors for coronary heart disease: implications of gender
Roeters van Lennep, J. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00388-1 · Cited by 300
Metabolism of Homocysteine Thiolactone in Human Cell Cultures
Jakubowski, H. (1997) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)67504-6 · Cited by 299
Folates and Cardiovascular Disease
Verhaar, M. C., Stroes, E., & Rabelink, T. J. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0102.102190 · Cited by 291
Homocysteine and Hyperhomocysteinaemia
Zaric, B. L., Obradovic, M., Bajic, V., Haidara, M. A., Jovanovic, M., & Isenovic, E. R. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867325666180313105949 · Cited by 281
De Backer, G., Ambrosioni, E., Broch-Johnsen, K., Brotons, C., Cifkova, R., Dallongeville, J., Ebrahim, S., Faergeman, O., Graham, I., Mancia, G., et al. (2003) · European Journal of Cardiovascular Prevention and Rehabilitation · doi:10.1097/00149831-200312001-00001 · Cited by 274
Nappo, F. (1999) · JAMA · doi:10.1001/jama.281.22.2113 · Cited by 270
Hermansen, K., Søndergaard, M., Høie, L., Carstensen, M., & Brock, B. (2001) · Diabetes Care · doi:10.2337/diacare.24.2.228 · Cited by 264
Folate, homocysteine, endothelial function and cardiovascular disease
Moat, S. J., Lang, D., McDowell, I. F. W., Clarke, Z. L., Madhavan, A. K., Lewis, M. J., & Goodfellow, J. (2004) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2003.08.010 · Cited by 261
Impaired Homocysteine Metabolism and Atherothrombotic Disease
Durand, P., Prost, M., Loreau, N., Lussier-Cacan, S., & Blache, D. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780275 · Cited by 261
Endothelial Dysfunction: The Link Between Homocysteine and Hydrogen Sulfide
Pushpakumar, S., Kundu, S., & Sen, U. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140706142335 · Cited by 256
Total homocysteine and cardiovascular disease
Nygård, O., Vollset, S. E., Refsum, H., Brattström, L., & Ueland, P. M. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00512.x · Cited by 256
Reactive Species in Sickle Cell Disease
ASLAN, M., THORNLEY‐BROWN, D., & FREEMAN, B. A. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06201.x · Cited by 136
Metadata
- Authors
- Robinson, K., Mayer, E. L., Miller, D. P., Green, R., van Lente, F., Gupta, A., Kottke-Marchant, K., Savon, S. R., Selhub, J., Nissen, S. E., Kutner, M., Topol, E. J., & Jacobsen, D. W.
- Venue
- Circulation
- Published
- 1995-11-15
- Volume
- 92
- Issue
- 10
- Pages
- 2825-2830
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2156158060
- Cited by
- 390
- References
- 30
- FWCI
- 21.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.